Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
67 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Cipla Europe from Antwerpen, company number BE0539790548, closed financial year 2025 with a result of € -1.3 million after tax. For that financial year Cipla Europe recorded revenue of € 24.8 million and equity of € 3.5 million. Compared with financial year 2024, the result moved from € -1.3 million to € -1.3 million. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 8, 2025.
€ 3.5 million
▼ 27% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1.3 million
▼ 4 % more loss than in 2024
Profit after tax over the fiscal year.
€ 929,317
▲ € 910,816 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -3.6 million.
People and assets in 2025
€ 2.8 million
▲ 27% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,104
▼ 43% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 736,191
▼ 77% vs 2024
Loans from banks and other lenders, long and short.
€ 34.8 million
▲ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 628 days on average.
€ 783,172
▲ 146% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 21,114,927 | € 21,201,823 | € 21,551,917 | € 24,782,987 | ▲ 15% |
| Profit after taxes | € 206,540 | € -2,056,334 | € -1,266,995 | € -1,320,219 | ▼ € 53,224 |
| Equity | € 8,139,450 | € 6,083,116 | € 4,816,121 | € 3,495,902 | ▼ 27% |
| Total debts | € 24,057,060 | € 21,768,203 | € 33,758,176 | € 36,886,107 | ▲ 9% |
| Cash | € 451,058 | € 636,043 | € 18,502 | € 929,317 | ▲ € 910,816 |
| Retained profit | € 1,039,450 | € -1,016,884 | € -2,283,879 | € -3,604,098 | ▼ € 1.3 million |
| Bank debt | € 1,892,783 | € 3,691,903 | € 3,240,924 | € 736,191 | ▼ 77% |
| Balance sheet total | € 32,836,510 | € 28,346,320 | € 38,952,297 | € 40,760,009 | ▲ 5% |
| Employees (FTE) | 6 | 16 | - | - |
By revenue, Cipla Europe ranks 2nd of 4 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Antwerpen that publish figures (fiscal year 2025).
Key figures of Cipla Europe, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2026 has not been filed yet; it was expected before 31 October 2026.
Ask about Cipla Europe the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Cipla Europe?
What happened at Cipla Europe in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Ankit Kirit Gudhka stepped down as director. NBB
- Sahid Hocine stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.3 million. Source: NBB ↗
- Ankit Kirit Gudhka became a director. NBB
- Saumil Chogle stepped down as director. NBB
- Saumil Chogle became a director. NBB
- Sahid Hocine became a director. NBB
- Capital increase of € 3 million, published in the Gazette. Source: Staatsblad ↗
In short
From € 206,540 profit in 2022 to € 1.3 million loss in 2025.
Paid € 341,241 in corporate taxes since 2022.
Best year ever: 2022, with € 206,540 profit.
Management
The shares are held by CIPLA HOLDING B.V. (100%) and CIPLA (EU) LIMITED (0%).
Directors
According to the 2025 annual accounts
Ankit Kirit Gudhka
Administrator-manager
since 2024 · until 2030
Saumil Chogle
Administrator-manager
since 2023 · until 2024
Sahid Hocine
Director
since 2022 · until 2028
Shareholders
CIPLA HOLDING B.V.
100%
CIPLA (EU) LIMITED
0%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
De Keyserlei 60C box 1301
2018 Antwerpen
De Keyserlei 60 box 1301
2018 Antwerpen
Active since 30 September 2013
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 67 companies are registered at this address.
All companies at this address →Sagax BE Industrial 1
€ 954,555 gross margin · 2025
BELMANTO GENERAL
€ -1,414 gross margin · 2025
VARAK
€ -29,183 gross margin · 2025
COOK BELGIUM
€ 17.9 million revenue · 2025
UNIVERSAL ASSOCIATION
€ 53,077 gross margin · 2025
+62 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Antwerpen
Same main activity (Groothandel in farmaceutische en medische artikelen), 13 active companies in Antwerpen, largest first.
€ 27.1 million revenue · 2025
€ 17.9 million revenue · 2025
€ 1.1 million gross margin · 2025
€ 668,813 gross margin · 2025
€ 437,785 gross margin · 2025
€ 70,614 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Cipla Holding B.V.(oprichter) 100%
Details
- Company number
- 0539.790.548
- VAT number
- BE 0539.790.548
- Registered office
- De Keyserlei 60C bus 1301, 2018 Antwerpen
- Names & denominations
- Cipla Europe
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 30 September 2013
- Peppol
- Active · Active since 27 Mar 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren